RecruitingTorsades de Pointe Caused by DrugLong QT Syndrome
Continuous Versus Intermittent cARdiac Electrical moNitorinG
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to validate the continuous patch monitoring system to evaluate cardiac arrhythmias in patients receiving drugs that can cause cardiac complications and compare the continuous patch system with standard electrocardiograms (ECGs).
Sponsor: Washington University School of Medicine
You may qualify if…
- ✓ Diagnosis of acute promyelocytic leukemia (APL) and being initiated on standard of care arsenic trioxide OR Diagnosis of solid tumor and being initiated on standard of care capecitabine (alone or as part of combination treatment) OR Diagnosis of solid tumor and being initiated on standard of care ribociclib (alone or as part of combination treatment)
- ✓ At least 18 years of age.
- ✓ No allergy to adhesive patches.
- ✓ Able to understand and willing to sign an IRB-approved written informed consent document.
You may not qualify if…
- ✕ Younger than 18 years of age
- ✕ Allergy to adhesive patches
Where it's recruiting
Missouri
St Louis
Source: ClinicalTrials.gov · NCT04336644 · last updated 2025-12-30